APO Research
Talk to an analyst

APO RESEARCH · REPORT

AT1 Receptor Antagonists

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AT1 Receptor Antagonists Industry Growth and Trends Forecast to 2032

20 December 2025109 pages

Choose your research edition.

Industry ResearchAT1 Receptor Antagonists Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal AT1 Receptor Antagonists Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal AT1 Receptor Antagonists Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AT1 Receptor Antagonists Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal AT1 Receptor Antagonists Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global AT1 Receptor Antagonists market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AT1 Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AT1 Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AT1 Receptor Antagonists is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AT1 Receptor Antagonists include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AT1 Receptor Antagonists market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AT1 Receptor Antagonists market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AT1 Receptor Antagonists market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AT1 Receptor Antagonists.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global AT1 Receptor Antagonists market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AT1 Receptor Antagonists Market by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

AT1 Receptor Antagonists Segment by Type

Valsartan

Telmisartan

Losartan

Irbesartan

Olmesartan

Azilsartan

AT1 Receptor Antagonists Segment by Application

Cardiovascular Diseases

Kidney Diseases

Hypertension

Other

AT1 Receptor Antagonists Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AT1 Receptor Antagonists market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AT1 Receptor Antagonists and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AT1 Receptor Antagonists.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of AT1 Receptor Antagonists manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of AT1 Receptor Antagonists in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Valsartan Table 2. Major Company of Telmisartan Table 3. Major Company of Losartan Table 4. Major Company of Irbesartan Table 5. Major Company of Olmesartan Table 6. Major Company of Azilsartan Table 7. Global AT1 Receptor Antagonists Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global AT1 Receptor Antagonists Sales by Type (2021-2026) & (k tons) Table 9. Global AT1 Receptor Antagonists Sales Market Share in Volume by Type (2021-2026) Table 10. Global AT1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 11. Global AT1 Receptor Antagonists Sales Market Share in Value by Type (2021-2026) Table 12. Global AT1 Receptor Antagonists Price by Type (2021-2026) & (US$/ton) Table 13. Global AT1 Receptor Antagonists Sales by Type (2027-2032) & (k tons) Table 14. Global AT1 Receptor Antagonists Sales Market Share in Volume by Type (2027-2032) Table 15. Global AT1 Receptor Antagonists Sales by Type (2027-2032) & (US$ Million) Table 16. Global AT1 Receptor Antagonists Sales Market Share in Value by Type (2027-2032) Table 17. Global AT1 Receptor Antagonists Price by Type (2027-2032) & (US$/ton) Table 18. North America AT1 Receptor Antagonists Sales by Type (2021-2026) & (k tons) Table 19. North America AT1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 20. Europe AT1 Receptor Antagonists Sales by Type (2021-2026) & (k tons) Table 21. Europe AT1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific AT1 Receptor Antagonists Sales by Type (2021-2026) & (k tons) Table 23. Asia-Pacific AT1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America AT1 Receptor Antagonists Sales by Type (2021-2026) & (k tons) Table 25. Latin America AT1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa AT1 Receptor Antagonists Sales by Type (2021-2026) & (k tons) Table 27. Middle East and Africa AT1 Receptor Antagonists Sales by Type (2021-2026) & (US$ Million) Table 28. AT1 Receptor Antagonists Industry Trends Table 29. AT1 Receptor Antagonists Industry Drivers Table 30. AT1 Receptor Antagonists Industry Opportunities and Challenges Table 31. AT1 Receptor Antagonists Industry Restraints Table 32. Global AT1 Receptor Antagonists Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global AT1 Receptor Antagonists Revenue Market Share by Company (2021-2026) Table 34. Global AT1 Receptor Antagonists Sales by Company (2021-2026) & (k tons) Table 35. Global AT1 Receptor Antagonists Sales Share by Company (2021-2026) Table 36. Global AT1 Receptor Antagonists Market Price by Company (2021-2026) & (US$/ton) Table 37. Global AT1 Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global AT1 Receptor Antagonists Major Company Production Sites and Headquarters Table 39. Global AT1 Receptor Antagonists Company, Product Type & Application Table 40. Global AT1 Receptor Antagonists Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global AT1 Receptor Antagonists by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global AT1 Receptor Antagonists Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global AT1 Receptor Antagonists Sales by Region (2021-2026) & (k tons) Table 45. Global AT1 Receptor Antagonists Sales Market Share in Volume by Region (2021-2026) Table 46. Global AT1 Receptor Antagonists Sales by Region (2021-2026) & (US$ Million) Table 47. Global AT1 Receptor Antagonists Sales Market Share in Value by Region (2021-2026) Table 48. Global AT1 Receptor Antagonists Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 49. Global AT1 Receptor Antagonists Sales by Region (2027-2032) & (k tons) Table 50. Global AT1 Receptor Antagonists Sales Market Share in Volume by Region (2027-2032) Table 51. Global AT1 Receptor Antagonists Sales by Region (2027-2032) & (US$ Million) Table 52. Global AT1 Receptor Antagonists Sales Market Share in Value by Region (2027-2032) Table 53. Global AT1 Receptor Antagonists Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 54. Global AT1 Receptor Antagonists Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global AT1 Receptor Antagonists Sales by Application (2021-2026) & (k tons) Table 56. Global AT1 Receptor Antagonists Sales Market Share in Volume by Application (2021-2026) Table 57. Global AT1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 58. Global AT1 Receptor Antagonists Sales Market Share in Value by Application (2021-2026) Table 59. Global AT1 Receptor Antagonists Price by Application (2021-2026) & (US$/ton) Table 60. Global AT1 Receptor Antagonists Sales by Application (2027-2032) & (k tons) Table 61. Global AT1 Receptor Antagonists Sales Market Share in Volume by Application (2027-2032) Table 62. Global AT1 Receptor Antagonists Sales by Application (2027-2032) & (US$ Million) Table 63. Global AT1 Receptor Antagonists Sales Market Share in Value by Application (2027-2032) Table 64. Global AT1 Receptor Antagonists Price by Application (2027-2032) & (US$/ton) Table 65. North America AT1 Receptor Antagonists Sales by Application (2021-2026) & (k tons) Table 66. North America AT1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 67. Europe AT1 Receptor Antagonists Sales by Application (2021-2026) & (k tons) Table 68. Europe AT1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific AT1 Receptor Antagonists Sales by Application (2021-2026) & (k tons) Table 70. Asia-Pacific AT1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America AT1 Receptor Antagonists Sales by Application (2021-2026) & (k tons) Table 72. Latin America AT1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa AT1 Receptor Antagonists Sales by Application (2021-2026) & (k tons) Table 74. Middle East and Africa AT1 Receptor Antagonists Sales by Application (2021-2026) & (US$ Million) Table 75. Teva Pharmaceutical Company Information Table 76. Teva Pharmaceutical Business Overview Table 77. Teva Pharmaceutical AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Teva Pharmaceutical AT1 Receptor Antagonists Product Portfolio Table 79. Teva Pharmaceutical Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. Sanofi AT1 Receptor Antagonists Product Portfolio Table 84. Sanofi Recent Development Table 85. Jhonson and Johnson Company Information Table 86. Jhonson and Johnson Business Overview Table 87. Jhonson and Johnson AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Jhonson and Johnson AT1 Receptor Antagonists Product Portfolio Table 89. Jhonson and Johnson Recent Development Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Novartis AT1 Receptor Antagonists Product Portfolio Table 94. Novartis Recent Development Table 95. Merck Company Information Table 96. Merck Business Overview Table 97. Merck AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 98. Merck AT1 Receptor Antagonists Product Portfolio Table 99. Merck Recent Development Table 100. Eli Lilly Company Information Table 101. Eli Lilly Business Overview Table 102. Eli Lilly AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 103. Eli Lilly AT1 Receptor Antagonists Product Portfolio Table 104. Eli Lilly Recent Development Table 105. Pfizer Company Information Table 106. Pfizer Business Overview Table 107. Pfizer AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 108. Pfizer AT1 Receptor Antagonists Product Portfolio Table 109. Pfizer Recent Development Table 110. GSK Company Information Table 111. GSK Business Overview Table 112. GSK AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 113. GSK AT1 Receptor Antagonists Product Portfolio Table 114. GSK Recent Development Table 115. Bayer Company Information Table 116. Bayer Business Overview Table 117. Bayer AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 118. Bayer AT1 Receptor Antagonists Product Portfolio Table 119. Bayer Recent Development Table 120. Bristol-Myers Squibb Company Information Table 121. Bristol-Myers Squibb Business Overview Table 122. Bristol-Myers Squibb AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 123. Bristol-Myers Squibb AT1 Receptor Antagonists Product Portfolio Table 124. Bristol-Myers Squibb Recent Development Table 125. Astra Zeneca Company Information Table 126. Astra Zeneca Business Overview Table 127. Astra Zeneca AT1 Receptor Antagonists Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 128. Astra Zeneca AT1 Receptor Antagonists Product Portfolio Table 129. Astra Zeneca Recent Development Table 130. North America AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 131. North America AT1 Receptor Antagonists Sales by Country (2021-2026) & (k tons) Table 132. North America AT1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 133. North America AT1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (k tons) Table 134. North America AT1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 135. North America AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 136. North America AT1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 137. North America AT1 Receptor Antagonists Market Share by Country (2021-2026) Table 138. North America AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 139. North America AT1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 140. Europe AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 141. Europe AT1 Receptor Antagonists Sales by Country (2021-2026) & (k tons) Table 142. Europe AT1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 143. Europe AT1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (k tons) Table 144. Europe AT1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 145. Europe AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 146. Europe AT1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 147. Europe AT1 Receptor Antagonists Market Share by Country (2021-2026) Table 148. Europe AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 149. Europe AT1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 150. Asia-Pacific AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 151. Asia-Pacific AT1 Receptor Antagonists Sales by Country (2021-2026) & (k tons) Table 152. Asia-Pacific AT1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 153. Asia-Pacific AT1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (k tons) Table 154. Asia-Pacific AT1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific AT1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 157. Asia-Pacific AT1 Receptor Antagonists Market Share by Country (2021-2026) Table 158. Asia-Pacific AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 159. Asia-Pacific AT1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 160. Latin America AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 161. Latin America AT1 Receptor Antagonists Sales by Country (2021-2026) & (k tons) Table 162. Latin America AT1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 163. Latin America AT1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (k tons) Table 164. Latin America AT1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 165. Latin America AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 166. Latin America AT1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 167. Latin America AT1 Receptor Antagonists Market Share by Country (2021-2026) Table 168. Latin America AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 169. Latin America AT1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 170. Middle East and Africa AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 171. Middle East and Africa AT1 Receptor Antagonists Sales by Country (2021-2026) & (k tons) Table 172. Middle East and Africa AT1 Receptor Antagonists Sales Market Share by Country (2021-2026) Table 173. Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Country (2027-2032) & (k tons) Table 174. Middle East and Africa AT1 Receptor Antagonists Sales Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa AT1 Receptor Antagonists Market Size by Country (2021-2026) & (US$ Million) Table 177. Middle East and Africa AT1 Receptor Antagonists Market Share by Country (2021-2026) Table 178. Middle East and Africa AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032) & (US$ Million) Table 179. Middle East and Africa AT1 Receptor Antagonists Market Share Forecast by Country (2027-2032) Table 180. Key Raw Materials Table 181. Raw Materials Key Suppliers Table 182. AT1 Receptor Antagonists Distributors List Table 183. AT1 Receptor Antagonists Customers List Table 184. Research Programs/Design for This Report Table 185. Authors List of This Report Table 186. Secondary Sources Table 187. Primary Sources List of Figures Figure 1. AT1 Receptor Antagonists Image Figure 2. Global AT1 Receptor Antagonists Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AT1 Receptor Antagonists Market Size (2021-2032) & (US$ Million) Figure 4. Global AT1 Receptor Antagonists Sales (2021-2032) & (k tons) Figure 5. Valsartan Image Figure 6. Global Valsartan Sales YoY Growth (2021-2032) & (k tons) Figure 7. Telmisartan Image Figure 8. Global Telmisartan Sales YoY Growth (2021-2032) & (k tons) Figure 9. Losartan Image Figure 10. Global Losartan Sales YoY Growth (2021-2032) & (k tons) Figure 11. Irbesartan Image Figure 12. Global Irbesartan Sales YoY Growth (2021-2032) & (k tons) Figure 13. Olmesartan Image Figure 14. Global Olmesartan Sales YoY Growth (2021-2032) & (k tons) Figure 15. Azilsartan Image Figure 16. Global Azilsartan Sales YoY Growth (2021-2032) & (k tons) Figure 17. Global AT1 Receptor Antagonists Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global AT1 Receptor Antagonists Market Share by Type 2025 VS 2032 Figure 19. North America AT1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 20. North America AT1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 21. Europe AT1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 22. Europe AT1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific AT1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific AT1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 25. Latin America AT1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 26. Latin America AT1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa AT1 Receptor Antagonists Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa AT1 Receptor Antagonists Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 AT1 Receptor Antagonists Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Cardiovascular Diseases Image Figure 32. Global Cardiovascular Diseases Sales YoY Growth (2021-2032) & (k tons) Figure 33. Kidney Diseases Image Figure 34. Global Kidney Diseases Sales YoY Growth (2021-2032) & (k tons) Figure 35. Hypertension Image Figure 36. Global Hypertension Sales YoY Growth (2021-2032) & (k tons) Figure 37. Other Image Figure 38. Global Other Sales YoY Growth (2021-2032) & (k tons) Figure 39. Global AT1 Receptor Antagonists Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global AT1 Receptor Antagonists Market Share by Application 2025 VS 2032 Figure 41. North America AT1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 42. North America AT1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 43. Europe AT1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 44. Europe AT1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 45. Asia-Pacific AT1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 46. Asia-Pacific AT1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 47. Latin America AT1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 48. Latin America AT1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 49. Middle East and Africa AT1 Receptor Antagonists Sales Market Share in Volume by Application in 2025 Figure 50. Middle East and Africa AT1 Receptor Antagonists Sales Market Share in Value by Application in 2025 Figure 51. North America AT1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. North America AT1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. North America AT1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. North America AT1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe AT1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Europe AT1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe AT1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Europe AT1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific AT1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Asia-Pacific AT1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific AT1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Asia-Pacific AT1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America AT1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 64. Latin America AT1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America AT1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Latin America AT1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa AT1 Receptor Antagonists Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 68. Middle East and Africa AT1 Receptor Antagonists Sales Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa AT1 Receptor Antagonists Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 70. Middle East and Africa AT1 Receptor Antagonists Market Share by Country: 2021 VS 2025 VS 2032 Figure 71. AT1 Receptor Antagonists Value Chain Figure 72. Key Raw Materials Price Figure 73. Manufacturing Cost Structure Figure 74. AT1 Receptor Antagonists Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Valsartan
  • Telmisartan
  • Losartan
  • Irbesartan
  • Olmesartan
  • Azilsartan
Applications
  • Cardiovascular Diseases
  • Kidney Diseases
  • Hypertension
  • Other
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global AT1 Receptor Antagonists Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global AT1 Receptor Antagonists Sales Estimates and Forecasts (2021-2032)
  5. 1.3 AT1 Receptor Antagonists Market by Type
  6. 1.3.1 Valsartan
  7. 1.3.2 Telmisartan
  8. 1.3.3 Losartan
  9. 1.3.4 Irbesartan
  10. 1.3.5 Olmesartan
  11. 1.3.6 Azilsartan
  12. 1.4 Global AT1 Receptor Antagonists Market Size by Type
  13. 1.4.1 Global AT1 Receptor Antagonists Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global AT1 Receptor Antagonists Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global AT1 Receptor Antagonists Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America AT1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe AT1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific AT1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America AT1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa AT1 Receptor Antagonists Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 AT1 Receptor Antagonists Industry Trends
  2. 2.2 AT1 Receptor Antagonists Industry Drivers
  3. 2.3 AT1 Receptor Antagonists Industry Opportunities and Challenges
  4. 2.4 AT1 Receptor Antagonists Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by AT1 Receptor Antagonists Revenue (2021-2026)
  2. 3.2 Global Top Players by AT1 Receptor Antagonists Sales (2021-2026)
  3. 3.3 Global Top Players by AT1 Receptor Antagonists Price (2021-2026)
  4. 3.4 Global AT1 Receptor Antagonists Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global AT1 Receptor Antagonists Major Company Production Sites & Headquarters
  6. 3.6 Global AT1 Receptor Antagonists Company, Product Type & Application
  7. 3.7 Global AT1 Receptor Antagonists Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global AT1 Receptor Antagonists Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 AT1 Receptor Antagonists Players Market Share by Revenue in 2025
  11. 3.8.3 2025 AT1 Receptor Antagonists Tier 1, Tier 2, and Tier 3
4 AT1 Receptor Antagonists Regional Status and Outlook
  1. 4.1 Global AT1 Receptor Antagonists Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global AT1 Receptor Antagonists Historic Market Size by Region
  3. 4.2.1 Global AT1 Receptor Antagonists Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global AT1 Receptor Antagonists Sales in Value by Region (2021-2026)
  5. 4.2.3 Global AT1 Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global AT1 Receptor Antagonists Forecasted Market Size by Region
  7. 4.3.1 Global AT1 Receptor Antagonists Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global AT1 Receptor Antagonists Sales in Value by Region (2027-2032)
  9. 4.3.3 Global AT1 Receptor Antagonists Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 AT1 Receptor Antagonists by Application
  1. 5.1 AT1 Receptor Antagonists Market by Application
  2. 5.1.1 Cardiovascular Diseases
  3. 5.1.2 Kidney Diseases
  4. 5.1.3 Hypertension
  5. 5.1.4 Other
  6. 5.2 Global AT1 Receptor Antagonists Market Size by Application
  7. 5.2.1 Global AT1 Receptor Antagonists Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global AT1 Receptor Antagonists Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global AT1 Receptor Antagonists Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America AT1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe AT1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific AT1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America AT1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa AT1 Receptor Antagonists Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical
  2. 6.1.1 Teva Pharmaceutical Company Information
  3. 6.1.2 Teva Pharmaceutical Business Overview
  4. 6.1.3 Teva Pharmaceutical AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical AT1 Receptor Antagonists Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi AT1 Receptor Antagonists Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Jhonson and Johnson
  14. 6.3.1 Jhonson and Johnson Company Information
  15. 6.3.2 Jhonson and Johnson Business Overview
  16. 6.3.3 Jhonson and Johnson AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jhonson and Johnson AT1 Receptor Antagonists Product Portfolio
  18. 6.3.5 Jhonson and Johnson Recent Developments
  19. 6.4 Novartis
  20. 6.4.1 Novartis Company Information
  21. 6.4.2 Novartis Business Overview
  22. 6.4.3 Novartis AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AT1 Receptor Antagonists Product Portfolio
  24. 6.4.5 Novartis Recent Developments
  25. 6.5 Merck
  26. 6.5.1 Merck Company Information
  27. 6.5.2 Merck Business Overview
  28. 6.5.3 Merck AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck AT1 Receptor Antagonists Product Portfolio
  30. 6.5.5 Merck Recent Developments
  31. 6.6 Eli Lilly
  32. 6.6.1 Eli Lilly Company Information
  33. 6.6.2 Eli Lilly Business Overview
  34. 6.6.3 Eli Lilly AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Eli Lilly AT1 Receptor Antagonists Product Portfolio
  36. 6.6.5 Eli Lilly Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer AT1 Receptor Antagonists Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 GSK
  44. 6.8.1 GSK Company Information
  45. 6.8.2 GSK Business Overview
  46. 6.8.3 GSK AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK AT1 Receptor Antagonists Product Portfolio
  48. 6.8.5 GSK Recent Developments
  49. 6.9 Bayer
  50. 6.9.1 Bayer Company Information
  51. 6.9.2 Bayer Business Overview
  52. 6.9.3 Bayer AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bayer AT1 Receptor Antagonists Product Portfolio
  54. 6.9.5 Bayer Recent Developments
  55. 6.10 Bristol-Myers Squibb
  56. 6.10.1 Bristol-Myers Squibb Company Information
  57. 6.10.2 Bristol-Myers Squibb Business Overview
  58. 6.10.3 Bristol-Myers Squibb AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Bristol-Myers Squibb AT1 Receptor Antagonists Product Portfolio
  60. 6.10.5 Bristol-Myers Squibb Recent Developments
  61. 6.11 Astra Zeneca
  62. 6.11.1 Astra Zeneca Company Information
  63. 6.11.2 Astra Zeneca Business Overview
  64. 6.11.3 Astra Zeneca AT1 Receptor Antagonists Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Astra Zeneca AT1 Receptor Antagonists Product Portfolio
  66. 6.11.5 Astra Zeneca Recent Developments
7 North America by Country
  1. 7.1 North America AT1 Receptor Antagonists Sales by Country
  2. 7.1.1 North America AT1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America AT1 Receptor Antagonists Sales by Country (2021-2026)
  4. 7.1.3 North America AT1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 7.2 North America AT1 Receptor Antagonists Market Size by Country
  6. 7.2.1 North America AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America AT1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 7.2.3 North America AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe AT1 Receptor Antagonists Sales by Country
  2. 8.1.1 Europe AT1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe AT1 Receptor Antagonists Sales by Country (2021-2026)
  4. 8.1.3 Europe AT1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 8.2 Europe AT1 Receptor Antagonists Market Size by Country
  6. 8.2.1 Europe AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe AT1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 8.2.3 Europe AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific AT1 Receptor Antagonists Sales by Country
  2. 9.1.1 Asia-Pacific AT1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific AT1 Receptor Antagonists Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific AT1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific AT1 Receptor Antagonists Market Size by Country
  6. 9.2.1 Asia-Pacific AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific AT1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America AT1 Receptor Antagonists Sales by Country
  2. 10.1.1 South America AT1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America AT1 Receptor Antagonists Sales by Country (2021-2026)
  4. 10.1.3 South America AT1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 10.2 South America AT1 Receptor Antagonists Market Size by Country
  6. 10.2.1 South America AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America AT1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 10.2.3 South America AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa AT1 Receptor Antagonists Sales by Country
  2. 11.1.1 Middle East and Africa AT1 Receptor Antagonists Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa AT1 Receptor Antagonists Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa AT1 Receptor Antagonists Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa AT1 Receptor Antagonists Market Size by Country
  6. 11.2.1 Middle East and Africa AT1 Receptor Antagonists Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa AT1 Receptor Antagonists Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa AT1 Receptor Antagonists Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 AT1 Receptor Antagonists Value Chain Analysis
  2. 12.1.1 AT1 Receptor Antagonists Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 AT1 Receptor Antagonists Production Mode & Process
  7. 12.2 AT1 Receptor Antagonists Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 AT1 Receptor Antagonists Distributors
  10. 12.2.3 AT1 Receptor Antagonists Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst